bioAffinity Technologies (BIAF) Enterprise Value (2022 - 2025)
Historic Enterprise Value for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$7.7 million.
- bioAffinity Technologies' Enterprise Value fell 86250.0% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.7 million, marking a year-over-year decrease of 86250.0%. This contributed to the annual value of -$1.1 million for FY2024, which is 6082.71% up from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' Enterprise Value is -$7.7 million, which was down 86250.0% from -$802835.0 recorded in Q2 2025.
- bioAffinity Technologies' Enterprise Value's 5-year high stood at -$444706.0 during Q1 2025, with a 5-year trough of -$13.5 million in Q3 2022.
- Its 4-year average for Enterprise Value is -$5.0 million, with a median of -$2.8 million in 2023.
- Per our database at Business Quant, bioAffinity Technologies' Enterprise Value surged by 9034.57% in 2024 and then tumbled by 86250.0% in 2025.
- Over the past 4 years, bioAffinity Technologies' Enterprise Value (Quarter) stood at -$11.4 million in 2022, then soared by 75.28% to -$2.8 million in 2023, then skyrocketed by 60.83% to -$1.1 million in 2024, then plummeted by 596.65% to -$7.7 million in 2025.
- Its Enterprise Value stands at -$7.7 million for Q3 2025, versus -$802835.0 for Q2 2025 and -$444706.0 for Q1 2025.